Cargando…
Extended-release ranolazine: critical evaluation of its use in stable angina
Coronary heart disease is the major cause of morbidity and mortality throughout the world, and is responsible for approximately one of every six deaths in the US. Angina pectoris is a clinical syndrome characterized by discomfort, typically in the chest, neck, chin, or left arm, induced by physical...
Autores principales: | Truffa, Adriano AM, Newby, L Kristin, Melloni, Chiara |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3166193/ https://www.ncbi.nlm.nih.gov/pubmed/21915171 http://dx.doi.org/10.2147/VHRM.S15560 |
Ejemplares similares
-
Utility of ranolazine in chronic stable angina patients
por: Patel, Pawan D, et al.
Publicado: (2008) -
Update on ranolazine in the management of angina
por: Codolosa, J Nicolás, et al.
Publicado: (2014) -
Ranolazine for Angina in Hypertrophic Cardiomyopathy
por: Amin, Akhtar, et al.
Publicado: (2018) -
Comparison of the efficacy and tolerability of ivabradine and ranolazine in patients of chronic stable angina pectoris
por: Chaturvedi, Aditi, et al.
Publicado: (2013) -
Emerging clinical role of ranolazine in the management of angina
por: Vadnais, David S, et al.
Publicado: (2010)